Quality Of Life in Patients With Malignant Biliary Obstruction
|ClinicalTrials.gov Identifier: NCT00579865|
Recruitment Status : Completed
First Posted : December 24, 2007
Last Update Posted : January 14, 2010
|Condition or disease||Intervention/treatment|
|Gallbladder Cancer Liver Cancer Bile Duct Cancer||Behavioral: questionnaires|
|Study Type :||Observational|
|Actual Enrollment :||124 participants|
|Official Title:||Impact of Biliary Drainage on Quality Of Life in Patients With Malignant Biliary Obstruction|
|Study Start Date :||May 2005|
|Actual Primary Completion Date :||January 2010|
|Actual Study Completion Date :||January 2010|
Patients scheduled for percutaneous drainage
complete the FACT-Hep, the SSQ, and the Visual Analog Scale for Pruritus Assessment at 1 week and 4 weeks post procedure.
Patients scheduled for a surgical bypass or resection of a high bile duct tumor.
complete the FACT-Hep, the SSQ, and the Visual Analog Scale for Pruritus Assessment at 1 week and 4 weeks post procedure. Patients who have undergone bypass or resection will complete an additional set of questionnaires at 9 and 14 weeks.
- To determine how surgical or percutaneous drainage affects HRQL scores in patients with MBO, and to determine if these changes are sustained or change over time. [ Time Frame: conclusion of the study ]
- To identify factors associated with changes in HRQL after drainage(e.g. diagnosis, level of obstruction, degree of pruritus) [ Time Frame: conclusion of the study ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00579865
|United States, New York|
|Memorial Sloan Kettering Cancer Center|
|New York, New York, United States, 10065|
|Principal Investigator:||Piera Robson, RN, BSN||Memorial Sloan Kettering Cancer Center|